Overlap between pathology of Alzheimer disease and vascular dementia

Alzheimer Disease and Associated Disorders

Volumn 13, Issue SUPPL. 3, 1999, Pages

  Kalaria, Raj N ^a   Ballard, Clive ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer disease; Cerebral infarction; Cerebral microvessels; Neuropathology; Vascular dementia; White matter lesions

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR DISEASE; GENETICS; HUMAN; MULTIINFARCT DEMENTIA; PATHOLOGY; REVIEW;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; CEREBROVASCULAR DISORDERS; DEMENTIA, VASCULAR; HUMANS;

EID: 0033202045     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199912003-00017     Document Type: Article

References (91)

1. Alzheimer A. Uber eine eigenartig Erkrankung der Hirnrinde. Allg Z Psychiatrie Psych Ger Med 1907;64:146-8.
2. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, VaD, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
3. Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L. Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand 1990;81: 349-51.
4. Blennow K, Wallin A, Uhlemann C, Gottfries C. White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991;83:187-93.
5. Bronge L, Fernaeus SE, Blomberg M, et al. White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype. Dement Geriatr Cogn Disord 1999;10:89-96.
6. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253-62.
7. Claudio L. Utrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol 1996;91: 6-14.
8. Cohen DL, Hedera P, Premkumar DRD, Friedland RP, Kalaria RN. Amyloid-β angiopathies masquerading as Alzheimer's disease. Ann NY Acad Sci 1997;826:390-5.
9. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
10. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
11. De Jong GI, De Vos RAI, Jansen Steur ENH, Luiten PGM. Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Ann NY Acad Sci 1997;826:56-74.
12. de la Monte SM. Quantitation of cerebral atrophy in preclinical and endstage Alzheimer's disease. Ann Neurol 1989;25:450-9.
13. de la Torre JC. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann NY Acad Sci 1997;826:75-91.
14. de la Torre JC, Hachinski V, eds. Cerebrovascular pathology in Alzheimer's disease, vol. 826. New York: Annals of the New York Academy of Sciences, 1997.
15. De Reuck J, Crevits L, De Coster W, Sieben G, vander Hecken H. Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology 1980;30:920-8.
16. Diaz FJ, Merskey H, Hachinski VC, et al. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. Arch Neurol 1991;48:1022-5.
17. Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques. Acta Neuropathol (Berl) 1982;57:239-12.
18. Elovaara I, Seppälä I, Palo J, Sulkava R, Erkinjuntti T. Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Acta Neurol Scand 1988;77:397-401.
19. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1998;9(suppl 1):6-12.
20. Erkinjuntti T, Hachinski V. Dementia post stroke. In: Physical medicine and rehabilitation: state of the art reviews, vol. 7. Philadelphia: Hanley & Belfus, 1993:195-212.
21. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997;63:749-53.
22. Ferrucci L, Guralnik JM, Salive ME, et al. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 1996;44:237-41.
23. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-2.
24. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. Br Med J 1996;312:608-11.
25. Glenner GG. Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). Med Hypotheses 1979;5: 1231-6.
26. Gray F, Chretien F, Cesaro P, et al. Creutzfeldt-Jakob disease and cerebral amyloid angiopathy. Acta Neuropathol 1994;88:106-11.
27. Haan J, Lanser JBK, Zijderveld I, van der Does IGF, Roos RAC. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Arch Neurol 1990;47:965-8.
28. Hampel H, Muller-Spahn F, Berger C, Haberl A, Ackenheil M, Hock C. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation. Dementia 1995;6:348-54.
29. Hardy J, Mann D, Wester P, Winblad B. An integrative hypothesis concerning the pathosenesis and profession of Alzheimer's disease. Neurobiol Aging 1986;7:489-502.
30. Henon H, Pasquier F, Durieu I, et al. Pre-existing stroke in patients: base-line frequency, associated factors and outcome. Stroke 1997;28:2429-36.
31. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease. CERAD Part XVIII. Neurology 1998;51:159-62.
32. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-4.
33. Johansson BB. Pathogenesis of vascular dementia: the possible role of hypertension. Dementia 1994;5:174-6.
34. Kalaria RN. The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovasc Brain Metab 1992;4:226-60.
35. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 1996;72:193-214.
36. Kalaria RN. Apolipoprotein E, arteriosclerosis and Alzheimer's disease. Lancet 1997;349:1174-5.
37. Kalaria RN, Bhatti SU, Palatinsky EA, et al. Accumulation of the β amyloid precursor protein at sites of ischemic injury in rat brain. NeuroReport 1993;4:211-4.
38. Kalaria RN, Cohen DL, Premkumar DRD, LaManna JC, Lust WD. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Mol Brain Res 1998;62:101-5.
39. Kalaria RN, Golde TE, Cohen ML, Younkin SG. Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier. Ann NY Acad Sci 1991;640:145-8.
40. Kalaria RN, Hedera P. Differential degeneration of the endothelium and basement membrane of capillaries in Alzheimer's disease. NeuroReport 1995;6:477-80.
41. Kalaria RN, Hedera P. Beta-amyloid vasoactivity in Alzheimer's disease [letter]. Lancet 1996;347:1492-3.
42. Kalaria RN, Kroon S. Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects. Acta Neuropathol 1992;84:606-12.
43. Kalaria RN, Pax AB. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res 1995;705:349-52.
44. Kalaria RN, Pax AB, Premkumar DRD, Lieberburg I. Production and increased detection of amyloid β-protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer disease. Mol Brain Res 1996;35:58-68.
45. Kawai M, Kalaria RN, Cras P, et al. Degeneration of amyloid precursor protein-containing smooth muscle cells in cerebral amyloid angiopathy. Brain Res 1993;623:142-6.
46. Kay D, May C, Papadopoulos N, et al. CSF and serum concentration of albumin and IgG in Alzheimer's disease. Neurobiol Aging 1987:8:21-5.
47. Kimura T, Hashimura T, Miyakawa T. Observations of microvessels in the brain with Alzheimer's disease by scanning electron microscopy. Jap J Psychiatry Neurol 1991;45:671-6.
48. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischaemic stroke: a population based study in Rochester, Minnesota (1960-1984). Neurology 1996;46:154-9.
49. Kosunen O, Soininen H, Paljarvi L, Heinonen O, Talasniemi S, Riekkinen PJ, Sr. Diagnostic accuracy of Alzheimer's disease: a neuropathological study. Acta Neuropathol (Berl) 1996;91:185-93.
50. Kosunen O, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995;26:743-8.
51. Leonardi A, Gandolfo C, Caponetto C, Arata L, Vecchia R. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J Neurol Sci 1985;67:253-61.
52. Leys D, Pasquier F, Scheletens P, eds. Stroke and Alzheimer's disease. In: Current issues in neurodegenerative disease, vol. 9. The Hague, The Netherlands: Holland Academic Graphics, 1998.
53. Leys D, Pruvo JP, Parent M, et al. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 1991;54:46-50.
54. Licandro A, Ferla S, Tavolato B. Alzheimer's disease and senile brains: an immunofluorescence study. Riv Patol Nerv Ment 1983;104:75-87.
55. Mann DMA, Davies JS, Hawkes J, Yates PO. Immunohistochemical staining of senile plaques. Neuropathol Appl Neurobiol 1982;8:55-61.
56. Margaglione M, Seripa D, Gravina C, et al. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian case-control study. Stroke 1998;29:399-403.
57. Mecocci P, Parnetti L, Reboldi GP, et al. Blood-brain barrier in a geriatric population: barrier function in degenerative and vascular dementia. Acta Neurol Scand 1991;84:210-3.
58. Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann NY Acad Sci 1997;826:103-16.
59. Munoz DG, Erkinjuntti T, Gaytan-Garcia S, Hachinski V. Serum protein leakage in Alzheimer's disease revisited. Ann NY Acad Sci 1997;826:173-89.
60. Nag S. Cerebral changes in chronic hypertension: combined permeability and immunohistochemical studies. Acta Neuropathol (Berl) 1984;62:178-84.
61. Nagy Z, Esiri MM, Joachim C, et al. Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis Assoc Disord 1998;12:182-9.
62. Nolan KA, Lino MM, Seligman AW, Blass JP. Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc 1998;46:597-604.
63. Notkola I-L, Sulkava R, Pekkanen J, et al. Serum total cholesterol, apolipoprotein E e4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20.
64. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52: 702-8.
65. Pasquier F, Leys D, Scheltens P. The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease. J Neural Transm Suppl 1998;54:117-27.
66. Perlmutter LS, Chui HC, Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 1990;24:677-86.
67. Perlmutter LS, Myers MA, Barrón E. Vascular basement membrane components and the lesions of Alzheimer's disease: light and electron microscopic analyses. Microsc Res Tech 1994;28:204-15.
68. Perry EK, Perry RH, M Roth, Tomlinson B. Cholinergic neuronal deficits in dementia. J Neurol Sci 1977;24:145-53.
69. Perry G, Smith MA, McCann CE, Siediak SL, Jones PK, Friedland RP. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res 1998;791:63-6.
70. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
71. Premkumar DRD, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E e4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology in Alzheimer's disease. Am J Pathol 1996;148: 2083-95.
72. Román GC. Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 1987;258:1782-8.
73. Scheibel AB, Duong T, Tomiyasu U. Denervation microangiopathy in senile dementia, Alzheimer type. Alzheimer Dis Assoc Disord 1987;1:19-37.
74. Scheltens P, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for a heterogeneity. Brain 1992;115:735-48.
75. Skoog I. The relationship between blood pressure and dementia: a review. Biomed Pharmacother 1997;51:367-75.
76. Skoog I, Hesse C, Aevarsson O, et al. A population study of Apo E genotype at the age of 85: relation to dementia, cerebrovascular disease and mortality. J Neurol Neurosurg Psychiatry 1998a;64:37-43.
77. Skoog I, Hesse C, Fredman P, Andreasson L-A, Palmertz B, Blennow K. Apolipoprotein E in cerebrospinal fluid in 85-year-olds. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white-matter lesions. Arch Neurol 1997;54:267-72.
78. Skoog I, Lernfelt B, Landahl S, et al. A 15-year longitudinal study on blood pressure and dementia. Lancet 1996;347:1141-5.
79. Skoog I, Wallin A, Fredman P, et al. A population-study on blood-brain barrier function in 85-year-olds. Relation to Alzheimer's disease and vascular dementia. Neurology 1998b;50:966-71.
80. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA 1997;277:813-7.
81. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC III. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995;131:162-9.
82. Stewart PA, Hayakawa K, Akers MA, Vinters HV. A mophometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 1992;67:734-42.
83. Van Gijn G. Leukoariosis and vascular dementia. Neurology 1998;51(suppl 3):S3-S8.
84. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke 1987;18:311-24.
85. Wahlund LO, Basun H, Almkvist O, et al. White matter hyperintensities in dementia: does it matter? Magn Reson Imaging 1994;12:387-94.
86. Wallin A. The overlap between Alzheimer's disease and vascular dementia: the role of white matter changes. Dement Geriatr Cogn Disord 1998;9(suppl 1):30-5.
87. Wallin A, Blennow K, Gottfries CG. Neurochemical abnormalities in vascular dementia. Dementia 1989;1:120-30.
88. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998;153:725-33.
89. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham offspring study. JAMA 1994;272:1666-71.
90. Wisniewski HM, Kozlowski PB. Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann NY Acad Sci 1982;396:119-31.
91. Yamaguchi F, Meyer JS, Fumihko S, Yamamoto M. Normal human aging and cerebral vasoconstrictive responses to hypocapnia. J Neurol Sci 1979;44:87-94.